KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.

BMC Cancer · 2022 · PMC9204993 · PMID 35710397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Survival analysis of cg17657618 showed a trend of longer survival time for the low CpG beta value group, though not statistically significant ( p = 0.089) (Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.